ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting

Description

This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of the leaking fluid.

Conditions

Oncology, Extravasation

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of the leaking fluid.

Feasibility Study for ivWatch® in Prevention of Extravasation of Vesicants in an Oncology Setting

ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting

Condition
Oncology
Intervention / Treatment

-

Contacts and Locations

Buffalo

Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States, 14263

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients requiring a peripheral IV for infusion of vesicant or vesicant-like agents (chemotherapy, other vesicant medications).
  • * PIV must be inserted
  • * Participant (or legal representative) must understand the nature of this study and verbally consent with the Research Study Information Sheet prior to receiving any study related procedure
  • * Patients who are not getting a vesicant, irritant or vesicant like fluid infused.
  • * Patients who are bruised, scarred, or tattooed in the area of the PIV.
  • * Patients with skin integrity issues at the site of the PIV.
  • * Patients who are on "light precautions."
  • * Not for use in power injectors.
  • * Not for use on mediports, implanted ports, IVAD, central lines, PICC lines.
  • * Patients without a cancer diagnosis.

Ages Eligible for Study

18 Years to 95 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Roswell Park Cancer Institute,

Study Record Dates

2025-05-17